Moderna, Inc.

Developer of an artificial intelligence-based research and deployment platform designed to create an artificial general intelligence that benefits all users. The company's platform offers an AI-based chatbot that serves as a universal interface for AI to interact with the digital world and engages in policy work, education, and outreach, enabling users to grow skills and gain knowledge with autonomous systems that outperform humans at economically valuable work.

AstraZeneca is a global pharmaceutical company focused on the research, development, and commercialization of prescription medicines. With around 90,000 employees in 85 countries, the company aims to harness scientific advancements for the benefit of people and society. AstraZeneca operates in various functions, including Clinical Development, Regulatory Affairs, Finance, IT, and Manufacturing. The company specializes in three main therapeutic areas: oncology, respiratory, and immunology. In oncology, AstraZeneca is dedicated to developing innovative treatments that aim to redefine cancer care. In the respiratory and immunology sectors, the company works to improve outcomes for patients with asthma and COPD, as well as other immune-driven diseases. Additionally, AstraZeneca has expanded its focus on rare diseases through its acquisition of Alexion, enhancing its capabilities in this area. The company is committed to advancing science and creating impactful therapies across multiple health conditions.